Navigation Links
Odyssey Thera is First to Install Next Generation High-Content Imaging Capability
Date:11/29/2011

ery programs and collaborative work with the United States Environmental Protection Agency (EPA), in which methods are being developed to improve detection of environmental toxicants," said Jane E. Lamerdin, Ph.D., Executive Director of R&D at Odyssey Thera.

About Odyssey Thera

Odyssey Thera, Inc. is a privately held biotechnology company based in San Ramon, California. The company is a leading developer of enabling technologies focused on deciphering biologically-relevant pathways in living human cells to improve the process of target and drug discovery and to advance methods for environmental chemical toxicity assessment. Patents owned by Odyssey Thera cover the use of the PCA technology in human cells, live animals, plants, diagnostic and biomarker, bioprocess, biodefense, and environmental applications. To learn more about Odyssey Thera, please visit www.odysseythera.com.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
2. Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™
3. Odyssey Thera Announces U.S. Patent for Technologies Enabling Protein Interaction Screening and Directed Evolution
4. Odyssey Thera to Participate in Expanded EPA Initiative
5. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
6. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
7. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
8. Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
9. Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
10. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
11. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has announced ... UK - November 16-18, 2015)" conference to their offering. ... including Columbia, Peru , Brazil ... Uruguay , Paraguay , Venezuela ... , Chile This seminar can be ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ) has ... Studies: Clinical Evidence (London, UK - November 10-11, ... This course has been designed specifically for ... required for medical devices and in-vitro diagnostic products. ... and the emphasis on high quality, appropriate clinical ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. Advances in understanding ... opened new avenues and possibilities for improved drug ... systems, enzymes, and receptors that control the penetration ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... Broadspire, a Crawford Company (NYSE: CRDA ; CRDB) ... provider, is proud to announce that Gary Anderberg, Ph.D., practice ... of Risk & Insurance magazine,s 2010 Risk Innovator ... a leader with Broadspire,s e-Triage system, which helps analyze claims ...
... Pa., Sept. 15 The GBS /CIDP ... symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory ... 5-7, 2010.  Over 400 medical professionals, current and former ... expected to attend the three-day event at the Dolce ...
Cached Medicine Technology:Broadspire’s Gary Anderberg Named a 2010 Risk Innovator 2Broadspire’s Gary Anderberg Named a 2010 Risk Innovator 3GBS/CIDP Foundation to Hold 11th International Symposium 2
(Date:9/3/2015)... ... September 03, 2015 , ... ... triggering cost increases for fully insured employer-sponsored health insurance plans, more employers are ... employees), according to data released from the 2014 United Benefit Advisors (UBA) Health ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... endpoint data collection, cloud analytics and workflow solutions today announced the complete ... Portugal, September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry ...
(Date:9/3/2015)... ... , ... AvePoint, the established leader in enabling enterprise collaboration across ... – AvePoint’s solution for facilitating two-way collaboration and external sharing without ever having to ... is the fifth consecutive year an AvePoint product has made the list. , The ...
(Date:9/3/2015)... ... September 03, 2015 , ... The new In-Office ... of Provo, Utah. The Clinicians Report is a leading information source to the ... throughout the U.S. Whiter Image's In-Office whitening kits were favorably validated for use ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Local filmmakers ... April Hannah & Michael Habernig from Path 11 Productions have had great success in ... age podcast has featured Hay House authors, Teal Swan who is the well known ...
Breaking Medicine News(10 mins):Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3
... may be able to help people// suffering from fibromyalgia. ... of Florida the cough medicine seemed to bring relief ... from fibromyalgia. ,Fibromyalgia syndrome occurs with extensive musculo-skeletal ... this diseases. More women than men report to be ...
... that asthmatic women have tendency of// irregular menstruation. ... severe stress, serious disease, anorexia nervosa, and drug addiction. ... women for 8 years to understand the possible link ... the research said that younger women with asthma and ...
... Scientists said that the problem of inability to read ... in visual processes as was thought in recent years. ... of perception than anything else. ,Dyslexia is one ... children, who have difficulty in verbal skills, abstract reasoning, ...
... researchers have established the association between adult urinary incontinence ... than 1000 Turkish women, the research says that the ... same for exhibiting lack of control in controlling urine ... may suffer from some faulty neural pathway that connects ...
... apnea syndrome affects a lot of people who are ... of having a difficult night, these people may have ... ,Obstructive sleep apnea syndrome (OSAS), also known as the ... problems, stroke, obesity, breathing problems, sexual dysfunction and clinical ...
... Women who had been diagnosed with breast cancer need to ... with lowering of levels of ovarian hormones and this could ... cancer patients who regularly exercised for about an hour daily. ... Health Study who were diagnosed with breast cancer of stages ...
Cached Medicine News:
... The Eppendorf Mastercycler Family offers fast temperature ... for optimal flexibility. Personal cards enable safe ... reliable transfer of individual protocols between different ... for PCR and come with a two-year ...
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate...
... 40 or 96 temperature cyclers, the gradient block ... range of up to 14 or 22 across ... temperature difference of up to 2C between adjacent ... test up to 12 different annealing temperatures in ...
... performance, high sample throughput instrument at a highly ... Flexible block format, a newly designed flexible heated ... Includes a four year or 80,000 Cycle Warranty! ... connected and run through a PC using Gensoft, ...
Medicine Products: